Lead

In February, Ernst & Young (EY) agreed to pay more than £100 million to settle a High Court claim brought by former FTSE 100 company NMC Health. The settlement resolves a dispute that began four years ago after NMC collapsed amid a fraud scandal that exposed serious governance failures.

Background

NMC Health was a UK‑based private hospital operator listed on the London Stock Exchange. In 2020 the company collapsed after revelations that it had engaged in a £1.2 billion fraud scheme involving falsified invoices and false financial statements. The scandal led to the resignation of its CEO and a forensic audit that uncovered widespread mis‑reporting.

Following the collapse, NMC Health’s former directors and shareholders pursued legal action against EY, the firm that had provided audit and advisory services to the company. The claim alleged that EY failed to detect or report the fraud, thereby contributing to the company’s downfall and the losses suffered by investors and patients.

What Happened

The High Court case was initiated in 2019. In February 2024, EY and NMC Health reached a confidential settlement, with EY paying over £100 million to the former FTSE 100 company. The terms of the settlement were not disclosed, but the payment was described as a “confidential agreement” that ended the legal dispute.

EY’s payment was reported by City A.M. as the largest settlement in the firm’s history related to a single client. The settlement was reached after four years of litigation, during which the court examined evidence of audit failures and the extent of EY’s involvement in the fraud.

Market & Industry Implications

1. Audit Firm Liability – The settlement underscores the potential liability that audit firms face when a client’s financial statements are found to be misleading. It may prompt firms to review audit procedures for high‑risk clients.

2. Regulatory Scrutiny – The case highlights the role of regulators in overseeing audit quality. The Financial Reporting Council and the Independent Office for Corporate Governance may intensify scrutiny of audit practices following the settlement.

3. Investor Confidence – Investors in the healthcare sector may reassess the risks associated with private hospital operators. The settlement could influence the pricing of shares in similar companies and affect the appetite for private equity investment in the sector.

What to Watch

  • EY’s public statements or regulatory filings regarding the settlement, which may provide further detail on the scope of the claim.
  • Any forthcoming reports from the Financial Reporting Council on audit quality that reference the NMC Health case.
  • Market reactions in the healthcare and audit sectors, including changes in share prices of comparable companies.